GSK plc : Bearish signal below GBp 1415
Entry price | Target | Stop-loss | Potential |
---|
GBX 1,421.95 |
GBX 1,350 |
GBX 1,455 |
+5.06% |
---|
Due to the bearish trend, the target price is fixed at GBp 1350 for GlaxoSmithKline.
From a fundamental viewpoint, the group is in a bad financial situation. For one year, analysts have downgraded their forecasts for earnings per share. This indicator is often a precursor of a declining profitability and a worsening climate of investors' confidence.
Technically, the share is in a downward trend. The moving averages are decreasing and are still above prices, thereby stopping any rebounds. The security is going toward the GBp 1414.5 support, a level that will represent an entry point when broke-down.
Taking into account fundamental and technical elements, investors can initiate a short position below GBp 1414.5 with the GBp 1350 as a target. A return towards GBp 1450, will invalidate the bearish strategy, which justifies a stop loss.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.